To develop MEA-capable compartmentalized microfluidic devices
NETRI and Axion BioSystems announce a collaboration to develop MEA-capable compartmentalized microfluidic devices. This joint venture provides the pre-clinical field with the ability to evaluate electrophysiological connectivity between neurons and other cell populations.
NETRI is a French start-up that develops organs-on-chip technologies for pre-clinical neuroscience applications.